Avenir Corporation’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Avenir Corporation's ADPT Position: Q3 2026 in Review
Avenir Corporation held its Adaptive Biotechnologies (ADPT) position steady in Q3 2026 at 74,865 shares worth $2.16M. The position accounts for 0.27% of the portfolio, ranked #28.
Avenir Corporation first reported a position in ADPT in Q2 2020 and has held it in 26 quarters since. 331 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Avenir Corporation held 74,865 shares of Adaptive Biotechnologies worth $2.16M as of Q3 2026.
- Avenir Corporation left its Adaptive Biotechnologies share count unchanged in Q3 2026.
- Adaptive Biotechnologies made up 0.27% of Avenir Corporation's portfolio in Q3 2026, its #28 holding.
- Avenir Corporation first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 26 quarters since.
- 331 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Avenir Corporation's 13F filing for Q3 2026, filed 13 Nov 2026.